NCT02264054View on ClinicalTrials.gov

Pharmacokinetics of Talsaclidine After Administration to Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 1999

Primary Completion Date

March 31, 1999

Conditions
Healthy
Interventions
DRUG

[14C]talsaclidine, oral

DRUG

[14C]talsaclidine, iv

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02264054 - Pharmacokinetics of Talsaclidine After Administration to Healthy Subjects | Biotech Hunter | Biotech Hunter